Tag

Venture capital Archives - JAG Shaw Baker

A Look Inside Unbound London 2017

By | Entrepreneurs, Events

In July, our associates Imran Bhatia and Robert Glass attended Unbound London at The Old Truman Brewery near London’s Brick Lane. The annual event brings together entrepreneurs, investors, corporates and journalists from around Europe to take a look at the impact of new disruptive technologies as well as different ways that emerging brands can establish a presence and increase brand loyalty in a fast-moving market.  The red-hot topic of the event was the concept of the startup culture. It was no surprise that the discussion centred around the importance of instilling business fundamentals and structure across start-ups as well as…

Read More

Atomico Leads $30 M Investment Round in AI Chip Company Graphcore

By | Artificial Intelligence, Client news, investors, Knowledge, Partner Insight, Robots

Artificial intelligence (AI) takes another step forward. Graphcore, a UK chip designer that designs chips specifically for AI, recently closed a $30 M round to support their continued expansion. The round was led by our client, Atomico and included existing investors Amadeus Capital, Robert Bosch Ventures Captial, C4 Ventures, Dell Technologies Capital, Draper Esprit Plc, Foundation Capital, Pitango and Samsung Catalyst Fund. Atomico is a London-based venture capital firm founded by Niklas Zennstrom, a co-founder of Skype. AI Everywhere According to a recent Bloomberg article, the investors in the round also included several machine learning experts such as Demis Hassabis, the co-founder and CEO of DeepMind. Owned by Alphabet Inc., DeepMind is an…

Read More

How To Commercialise Life Sciences: Focus On The Basics

By | Biotech, Current Affairs, Guest Posts, Knowledge, Life Sciences

Life sciences research can translate into solutions, products and companies that provide significant benefit to both society and the economy. Today’s dynamic ecosystem presents tremendous opportunities for life sciences innovators given technological advances and rapidly changing market realities. Although the environment for commercialisation has changed dramatically over the last few decades, the basic principles of making it a success remain the same. A commercialisation plan enables innovators to set out and communicate their strategy to others. It should offer a clear and concise overview of the technology’s market potential and the planned route to commercialisation. It should also illustrate how…

Read More

Innovative Financing Instruments: A Better Alternative?

By | Documentation, Entrepreneurs, Knowledge

As discussed in The New World Order of Innovative Financing, investors are increasingly opting to invest into companies in advance of formal funding rounds (including seed rounds). In the UK, these investments are usually made through convertible loan notes or advanced subscription agreements (known as ASAs). In the US similar instruments like Simple Agreement for Future Equity (SAFE) by Y Combinator and Keep It Simple Security (KISS) from 500 Startups have seen increased usage. In this post, we’re look at the advantages and disadvantages of these instruments from the both the investor and company perspectives. We’ll also look at what…

Read More

Artificial Intelligence, Robots And Techcrunch Disrupt

By | Artificial Intelligence, Biotech, Current Affairs, Entrepreneurs, Events, Investor and VC News, Knowledge, Robots

  In early December, Techcrunch Disrupt London came to town. The event hosts Startup Battlefield which gathers early stage startups together on one stage to compete for the Disrupt Cup and a cash prize. As expected, the agenda was jam-packed with a wide-range topics from Brexit and walking robot dogs to flying cars and the continued disruption and innovation of Fintech. On the VC front On the venture capital front, Niklas Zennström, Atomico said that early stage Seed and Series A investments in Europe are now on par with the US, both in terms of amount of capital invested and number of companies….

Read More

Client News: Doctify Raises Series A Funding Round

By | Client news, Entrepreneurs, Investor and VC News, Startups

Congratulations to our client Doctify Limited on raising more than $1M in their Series A funding round led by Amadeus Capital. We advised Doctify from their inception and their initial seed funding through to their Series A funding.  It’s been exciting to see their success from the start! Doctify is a new healthcare booking platform that gives patients a tool to search for specialist doctors, compare reviews and prices and book online appointments.  In a January article in the Evening Standard, the company says it aims to become the go-to online health platform.

Read More

Nick Crabtree Elevated To Partner

By | Brand, Current Affairs, Knowledge, M&A, Partner Insight, People

Today, we’re delighted to announce the elevation of Nick Crabtree to partner in our Corporate team. Nick is an influential member of the team at JAG Shaw Baker and since he joined the firm in early 2015, it’s remarkable to see how he’s helped the team deliver and close more than 200 transactions in that time. Nick has also been lead attorney on many key client mandates and has helped dozens of clients through successful M&A and investment transactions in the retail and technology markets – notably the sale of Fits.me to Rakuten and the sale of Wool and the…

Read More

The Effect Of Brexit On Venture Investing

By | Brand, Current Affairs, Entrepreneurs, Investor and VC News, Knowledge, Partner Insight

The Brexit Referendum has come and gone but has left a legacy of conversation and debate in the UK and around the world. From education and trade issues to tourism and technology, Brexit has been talked about a great deal (probably too much!) over the last two weeks. As a law firm at the heart of the UK’s thriving technology and life science sectors, we have experienced firsthand the concerns of entrepreneurs and investors alike. We wanted to candidly share our views on what we’re seeing as effects of Brexit vote – and what we therefore might expect to see – in…

Read More

Our New Venture Capital Associate

By | People

Felicity Mithen has joined the firm as a corporate lawyer working in the venture capital and technology practice. She joins the firm from Slaughter and May in London, where she trained before qualifying as a solicitor in England and Wales in 2015. She has previously worked with a broad range of private and public companies in industries including IT, consumer goods, energy, pharmaceuticals, commercial real estate and financial services. Felicity has a bachelor degree of arts in history from Durham University and a master’s degree in the history of medicine from McGill University, Montreal.

Read More

Our New Associate: Philip O’Reilly

By | Entrepreneurs, People

Philip O’Reilly is one of our new associates in venture capital at JAG Shaw Baker. Phillip specializes in advising venture capital investors and early stage companies on all aspects of financings, general corporate and regulatory matters. Philip trained with McCann FitzGerald in Dublin and qualified as a solicitor in 2011. Notable work included leading a cross-border transaction team in consolidating an international fund manager’s £2 billion worth of assets to a single onshore jurisdiction.   Other corporate clients included a range of UK-based and international companies operating in the financial services sector. Philip has also worked at Google, where he…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close